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General Information: Unless otherwise noted, all commercial materials were used without further 
purification. Anhydrous solvents obtained from Aladdin and Adamas were used directly without 
further purification, and solvents obtained from other commercial suppliers were used after 
purification as specified in Purification of Laboratory Chemicals, 6th Ed. Nuclear magnetic 
resonance (NMR) spectra were recorded with a Bruker AVANCE 400MHz instrument. 1H and 13C 
chemical shifts are reported in ppm downfield of tetramethylsilane and referenced to residual solvent 
peak (CHCl3 = 7.26 (1H NMR), DMSO = 2.50 (1H NMR), CDCl3 = 77.16 (13C NMR)) unless 
otherwise noted. Multiplicities are reported using the following abbreviations: s = singlet, d = doublet, 
t = triplet, q = quartet, m = multiplet, br = broad resonance. High-resolution mass spectra for new 
compounds were recorded at Mass Spectrometry Facilities, Zhejiang University. X-ray diffraction 
experiments were performed at X-Ray Facilities, Zhejiang University. 
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Experimental Procedures: 
Preparation of Lactic Acid Substrates 
(S)-2-Methoxy-N-(quinolin-8-yl)propanamide (1a) 
 
To a stirred solution of (S)-2-methoxypropanoic acid 1 (10.41 g, 100 mmol) in dry dichloromethane 
(300 mL), 4-methylmorpholine (NMM, 11.5 mL, 105 mmol) was added slowly at 0 °C. After the 
solution was stirred for five minutes, iso-butyl carbonochloridate (13.3 mL, 105 mmol) was added 
dropwise slowly at 0 °C. The mixture was then stirred at room temperature for 1.5 h. A solution of 
8-aminoquinoline (8.65 g, 60 mmol) in dry dichloromethane (50 mL) was slowly added to the reaction 
at 0 °C. After the reaction was stirred at room temperature overnight, the resulting mixture was then 
washed by aqueous HCl (100 mL, 0.1 M), saturated Na2CO3 (100 mL), brine (100 mL), and dried over 
anhydrous MgSO4. Evaporation of organic solvent and purification by silica gel column 
chromatography in 6:3:1 petroleum ether: dichloromethane: ethyl acetate, afforded the pure 
8-aminoquinoline amide 1a (13.12 g, 95%) as a white solid. 1H NMR (400 MHz, CDCl3) δ 10.80 (s, 
1H), 8.86 (dd, J = 4.0, 1.6 Hz, 1H), 8.80 (dd, J = 6.4, 2.4 Hz, 1H), 8.16 (dd, J = 8.4, 1.6 Hz, 1H), 7.57 
– 7.52 (m, 2H), 7.46 (dd, J = 8.4, 4.4 Hz, 1H), 3.99 (q, J = 6.8 Hz, 1H), 3.58 (s, 3H), 1.55 (d, J = 6.8 Hz, 
3H); 13C NMR (101 MHz, CDCl3) δ 170.89, 148.63, 138.92, 137.77, 136.20, 133.95, 129.51, 128.38, 
128.03, 127.27, 126.60, 122.06, 121.69, 116.63, 84.55, 59.32, 39.58; HRMS (EI) m/z: 230.1058(M+), 
calc. for C13H14N2O2: 230.1055. 
(S)-2-Ethyloxy-N-(quinolin-8-yl)propanamide (1b) 
O HN
O
N
 
The preparation of 1b followed the same procedure of 1a except using (S)-2-ethyloxypropanoic acid 
instead of (S)-2-methoxypropanoic acid. The compound 1b was obtained as a light yellow solid. 1H 
NMR (400 MHz, CDCl3) δ 10.93 (s, 1H), 8.85 (dd, J = 4.0, 1.1 Hz, 1H), 8.79 (dd, J = 6.6, 1.9 Hz, 
1H), 8.16 (dd, J = 8.2, 1.1 Hz, 1H), 7.71 – 7.50 (m, 2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 4.06 (q, J = 
6.8 Hz, 1H), 3.84 – 3.60 (m, 2H), 1.55 (d, J = 6.8 Hz, 3H), 1.41 (t, J = 7.0 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ 172.67, 148.64, 139.09, 136.29, 134.28, 128.14, 127.40, 121.93, 121.74, 116.59, 
77.61, 66.28, 19.24, 15.54; HRMS (EI) m/z: 244.1214(M+), calc. for C14H16N2O2: 244.1212. 
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Optimization of Reaction Conditions Mono-arylation of 1a 
(1) Optimization of Base Additives (t-AmylOH used as solvent)  
 
Entry Base Yield 3a 
1 K2CO3 17% 
2 KOAc trace 
3 K3PO4 26% 
4 LiOAc 0 
5 NaOAc 0 
6 Na2CO3 trace 
7 CsOAc trace 
8 Cs2CO3 18% 
Reaction conditions: 1a (0.20 mmol, 1.0 eq), 2a (0.30 mmol, 1.5 eq), Pd(OAc)2 (0.02 mmol, 10 
mol%), base (0.30 mmol, 1.5 eq), t-AmylOH (2.0 ml), reaction for 24 hours at 85 °C and under N2 
atmosphere. 
(2) Optimization of Silver(I) Salt Additives (t-AmylOH used as solvent) 
 
Entry Base Yield 3a 
1 AgOAc 16% 
2 AgF 65% 
3 AgTFA 0 
4 Ag2CO3 25% 
5 Ag2O 50% 
6 Ag3PO4 trace 
7 AgOCN trace 
8 AgBF4 0 
9 AgOPiv trace 
Reaction conditions: 1a (0.20 mmol, 1.0 eq), 2a (0.30 mmol, 1.5 eq), Pd(OAc)2 (0.02 mmol, 10 
mol%), silver salt (0.30 mmol, 1.5 eq), t-AmylOH (2.0 ml), reaction for 24 hours at 85 °C and under 
N2 atmosphere. 
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(3) Optimization of Solvent (AgF used as silver salt additive) 
 
Entry Solvent Yield 3a 
1 t-AmylOH 65% 
2 DCE 51% 
3 THF 30% 
4 1,4-dioxane 18% 
5 PhMe 14% 
6 MeCN 0 
7 DMF 60% 
8 DMAc 54% 
9 Acetone 52% 
10 MeOH 64% 
11 a t-AmylOH 75% 
12 a, b t-AmylOH 64% 
13 a, c t-AmylOH 81% d 
14 a, c DMSO trace 
15 a, c NMP 45% 
Reaction conditions: 1a (0.20 mmol, 1.0 eq), 2a (0.30 mmol, 1.5 eq), Pd(OAc)2 (0.02 mmol, 10 
mol%), AgF (0.30 mmol, 1.5 eq), solvent (2.0 ml), reaction for 24 hours at 85 °C and under N2 
atmosphere. a 3.0 equiv AgF was used; b 1.2 eq 2a was used; c reaction for 12 hours; d isolated yield. 
(S)-2-Methoxy-3-(4-methoxy-3-nitrophenyl)-N-(quinolin-8-yl)propanamide (3a) 
 
The title compound was prepared under the optimized condition. The crude product was purified by 
silica gel column chromatography in 4:1 petroleum ether:ethyl acetate, providing 3a as a white solid 
(61.5 mg, 81%). 1H NMR (400 MHz, CDCl3) δ 10.65 (s, 1H), 8.79 (dd, J = 4.4, 2.0 Hz, 1H), 8.77 – 
8.72 (m, 1H), 8.12 (dd, J = 8.4, 1.6 Hz, 1H), 7.84 (d, J = 2.4 Hz, 1H), 7.54 – 7.49 (m, 2H), 7.45 – 7.41 
(m, 2H), 6.90 (d, J = 8.4 Hz, 1H), 4.03 (dd, J = 7.6, 3.6 Hz, 1H), 3.82 (s, 3H), 3.53 (s, 3H), 3.24 (dd, J 
= 14.4, 3.6 Hz, 1H), 3.07 (dd, J = 14.4, 7.6 Hz, 1H).13C NMR (101 MHz, CDCl3) δ 170.06, 151.79, 
148.70, 139.27, 138.81, 136.20, 135.41, 133.62, 129.78, 127.99, 127.16, 126.76, 122.24, 121.74, 
116.66, 113.37, 83.69, 59.19, 56.47, 37.72. HRMS (EI) m/z: 381.1329 (M+), calc. for C20H19N3O5: 
381.1325. 
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General Procedure (GP) for Mono-arylation of Lactic Acid Derivative 
To a 30-mL resealable Schlenk flask was added 1a (46.1 mg, 0.2 mmol), Pd(OAc)2 (4.5 mg, 0.02 
mmol), aryl iodide (0.3 mmol), AgF (76.1 mg, 0.6 mmol), and t-AmylOH (2.0 mL). The Schlenk 
flask was charged with N2. The mixture was stirred at 85 °C for 12 hours. After cooling to room 
temperature, the reaction was diluted with dichloromethane (5 mL), then filtered through a pad of 
Celite and washed by dichloromethane (20 mL). Evaporation of organic solvent and purification by 
column chromatography gave the corresponding product. 
Scope of alkyl iodides:  
I I I I
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(S)-2-Methoxy-3-phenyl-N-(quinolin-8-yl)propanamide (3b) 
 
The compound 3b was prepared according to the GP and purified by column chromatography in 
toluene: ethyl acetate = 12:1. 3b was obtained as a light yellow solid (45.5 mg, 74%). 1H NMR (400 
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MHz, CDCl3) δ 10.81 (s, 1H), 8.89 – 8.79 (m, 2H), 8.13 (dd, J = 8.3, 1.3 Hz, 1H), 7.59 – 7.50 (m, 
2H), 7.43 (dd, J = 8.3, 4.2 Hz, 1H), 7.39 – 7.34 (m, 2H), 7.33 – 7.27 (m, 2H), 7.25 – 7.19 (m, 1H), 
4.09 (dd, J = 8.7, 3.5 Hz, 1H), 3.49 (s, 2H), 3.33 (dd, J = 14.2, 3.4 Hz, 1H), 3.08 (dd, J = 14.2, 8.7 
Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 170.89, 148.63, 138.92, 137.77, 136.20, 133.95, 129.51, 
128.38, 128.03, 127.27, 126.60, 122.06, 121.69, 116.63, 84.55, 59.32, 39.58; HRMS (EI) m/z: 
306.1368 (M+); calc. for C19H18N2O2: 306.1368. 
(S)-2-Methoxy-N-(quinolin-8-yl)-3-(p-tolyl)propanamide (3c) 
 
The compound 3c was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3c was obtained as a colorless oil (45.8 mg, 72%). 1H NMR 
(400 MHz, CDCl3) δ 10.77 (s, 1H), 8.93 – 8.73 (m, 2H), 8.13 (dd, J = 8.2, 1.3 Hz, 1H), 7.60 – 7.48 
(m, 2H), 7.42 (dd, J = 8.2, 4.2 Hz, 1H), 7.22 (d, J = 7.8 Hz, 2H), 7.08 (d, J = 7.7 Hz, 2H), 4.04 (dd, 
J = 8.6, 3.5 Hz, 1H), 3.48 (s, 3H), 3.26 (dd, J = 14.2, 3.3 Hz, 1H), 3.03 (dd, J = 14.2, 8.6 Hz, 1H), 
2.28 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 171.02, 148.63, 139.01, 136.21, 136.07, 134.68, 134.06, 
129.39, 129.11, 128.08, 127.31, 122.03, 121.68, 116.71, 84.73, 59.29, 39.20, 21.13; HRMS (EI) m/z: 
320.1523 (M+); calc. for C20H20N2O2: 320.1525. 
(S)-2-Methoxy-N-(quinolin-8-yl)-3-(m-tolyl)propanamide (3d) 
 
The compound 3d was prepared according to the GP and purified by column chromatography in 
toluene: ethyl acetate = 20:1. 3d was obtained as a colorless oil (46.3 mg, 72%). 1H NMR (400 MHz, 
CDCl3) δ 10.77 (s, 1H), 8.97 – 8.67 (m, 2H), 8.14 (dd, J = 8.2, 1.4 Hz, 1H), 7.63 – 7.48 (m, 2H), 
7.43 (dd, J = 8.2, 4.2 Hz, 1H), 7.22 – 7.09 (m, 3H), 7.01 (d, J = 6.8 Hz, 1H), 4.06 (dd, J = 8.8, 3.4 
Hz, 1H), 3.48 (s, 3H), 3.27 (dd, J = 14.2, 3.2 Hz, 1H), 3.01 (dd, J = 14.2, 8.8 Hz, 1H), 2.29 (s, 3H); 
13C NMR (101 MHz, CDCl3) δ 171.06, 148.66, 139.07, 137.95, 137.78, 136.24, 134.10, 130.35, 
128.31, 128.12, 127.39, 127.35, 126.53, 122.05, 121.71, 116.74, 84.77, 59.37, 39.71, 21.46; HRMS 
(EI) m/z: 320.1520 (M+); calc. for C20H20N2O2: 320.1525. 
(S)-2-Methoxy-3-(4-methoxyphenyl)-N-(quinolin-8-yl)propanamide (3e) 
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The compound 3e was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3e was obtained as a colorless oil (36.8 mg, 55%). 1H NMR 
(400 MHz, CDCl3) δ 10.76 (s, 1H), 8.99 – 8.76 (m, 2H), 8.16 (d, J = 8.2 Hz, 1H), 7.61 – 7.51 (m, 
2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 7.27 (d, J = 7.9 Hz, 2H), 6.83 (d, J = 8.0 Hz, 2H), 4.05 (dd, J = 
8.1, 3.1 Hz, 1H), 3.77 (s, 3H), 3.51 (s, 3H), 3.26 (dd, J = 14.3, 3.1 Hz, 1H), 3.04 (dd, J = 14.3, 8.4 
Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 170.98, 158.36, 148.63, 138.95, 136.20, 133.99, 130.51, 
129.73, 128.05, 127.28, 122.04, 121.68, 116.65, 113.78, 84.72, 59.28, 55.23, 38.65; HRMS (EI) m/z: 
336.1479 (M+); calc. for C20H20N2O3: 336.1474. 
(S)-2-Methoxy-3-(3-methoxyphenyl)-N-(quinolin-8-yl)propanamide (3f) 
 
The compound 3f was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3f was obtained as a white solid (54.0 mg, 80%). 1H NMR (400 
MHz, CDCl3) δ 10.78 (s, 1H), 8.98 – 8.71 (m, 2H), 8.15 (dd, J = 8.3, 1.5 Hz, 1H), 7.60 – 7.50 (m, 
2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 7.20 (t, J = 7.8 Hz, 1H), 6.99 – 6.84 (m, 2H), 6.75 (dd, J = 8.2, 
1.7 Hz, 1H), 4.08 (dd, J = 8.6, 3.4 Hz, 1H), 3.76 (s, 3H), 3.50 (s, 3H), 3.29 (dd, J = 14.2, 3.2 Hz, 
1H), 3.04 (dd, J = 14.2, 8.7 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ = 170.95, 159.70, 148.70, 
139.42, 139.06, 136.27, 134.07, 129.37, 128.13, 127.35, 122.11, 121.99, 121.74, 116.74, 114.95, 
112.41, 84.59, 59.40, 55.27, 39.73; HRMS (EI) m/z: 336.1476 (M+); calc. for C20H20N2O3: 
336.1474. 
(S)-2-Methoxy-3-(2-methoxyphenyl)-N-(quinolin-8-yl)propanamide (3g) 
 
The compound 3g was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3g was obtained as a colorless oil (27.7 mg, 41%). 1H NMR 
(400 MHz, CDCl3) δ 10.76 (s, 1H), 8.99 – 8.68 (m, 2H), 8.14 (dd, J = 8.2, 1.4 Hz, 1H), 7.58 – 7.49 
(m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 7.32 – 7.25 (m, 1H), 7.20 (td, J = 8.0, 1.4 Hz, 1H), 6.89 (t, J 
= 7.4 Hz, 1H), 6.83 (d, J = 8.1 Hz, 1H), 4.19 (dd, J = 8.6, 4.3 Hz, 1H), 3.81 (s, 3H), 3.45 (s, 3H), 
3.41 (dd, J = 14.0, 4.2 Hz, 1H), 3.02 (dd, J = 14.0, 8.6 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ = 
171.43, 157.82, 148.61, 139.05, 136.25, 134.31, 131.48, 128.12, 128.00, 127.39, 126.08, 121.86, 
121.69, 120.45, 116.69, 110.35, 83.15, 59.22, 55.45, 34.67; HRMS (EI) m/z: 336.1474 (M+); calc. 
for C20H20N2O3: 336.1474. 
(S)-3-(4-(tert-Butyl)phenyl)-2-methoxy-N-(quinolin-8-yl)propanamide (3h) 
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The compound 3h was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3h was obtained as a colorless oil (50.5 mg, 70%). 1H NMR 
(400 MHz, CDCl3) δ 10.77 (s, 1H), 8.91 – 8.77 (m, 2H), 8.14 (dd, J = 8.3, 1.6 Hz, 1H), 7.59 – 7.50 
(m, 2H), 7.43 (dd, J = 8.3, 4.2 Hz, 1H), 7.34 – 7.26 (m, 4H), 4.09 (dd, J = 8.6, 3.4 Hz, 1H), 3.51 (s, 
3H), 3.29 (dd, J = 14.3, 3.4 Hz, 1H), 3.06 (dd, J = 14.3, 8.6 Hz, 1H), 1.28 (s, 9H); 13C NMR 
(100MHz, CDCl3) δ 171.10, 149.33, 148.62, 138.95, 136.21, 134.69, 134.03, 129.14, 128.05, 127.30, 
125.30, 122.02, 121.68, 116.63, 84.63, 59.29, 39.13, 34.44, 31.43; HRMS (EI) m/z: 362.1991 (M+); 
calc. for C23H26N2O2: 362.1994.  
(S)-3-(4-Fluorophenyl)-2-methoxy-N-(quinolin-8-yl)propanamide (3i) 
 
The compound 3i was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3i was obtained as a white solid (51.1 mg, 79%). 1H NMR (400 
MHz, CDCl3) δ 10.72 (s, 1H), 8.82 (dd, J = 4.0, 1.2 Hz, 1H), 8.79 (dd, J = 6.3, 2.5 Hz, 1H), 8.15 (dd, 
J = 8.2, 1.0 Hz, 1H), 7.60 – 7.49 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 7.32 – 7.23 (m, 2H), 6.95 (t, 
J = 8.7 Hz, 2H), 4.03 (dd, J = 8.2, 3.5 Hz, 1H), 3.50 (s, 3H), 3.26 (dd, J = 14.3, 3.4 Hz, 1H), 3.05 
(dd, J = 14.3, 8.2 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 170.68, 161.90(d, JC-F = 242.8 Hz), 
148.71, 139.01, 136.28, 133.95, 133.32(d, JC-F = 3.2 Hz), 131.08(d, JC-F = 7.8 Hz), 128.12, 127.32, 
122.17, 121.76, 116.73, 115.19(d, JC-F = 21.0 Hz), 84.47, 59.32, 38.63; HRMS (EI) m/z: 324.1271 
(M+); calc. for C19H17FN2O2: 324.1274. 
(S)-3-(4-Chlorophenyl)-2-methoxy-N-(quinolin-8-yl)propanamide (3j) 
 
The compound 3j was prepared according to the GP and purified by column chromatography in 
toluene: ethyl acetate = 12:1. 3j was obtained as a yellow solid (56.1 mg, 83%). 1H NMR (400 MHz, 
CDCl3) δ 10.72 (s, 1H), 8.81 (dd, J = 4.2, 1.6 Hz, 1H), 8.79 (dd, J = 6.6, 2.4 Hz, 1H), 8.13 (dd, J = 
8.2, 1.3 Hz, 1H), 7.59 – 7.48 (m, 2H), 7.43 (dd, J = 8.2, 4.2 Hz, 1H), 7.24 (q, J = 8.4 Hz, 4H), 4.03 
(dd, J = 8.2, 3.5 Hz, 1H), 3.49 (s, 3H), 3.25 (dd, J = 14.2, 3.4 Hz, 1H), 3.04 (dd, J = 14.2, 8.2 Hz, 
1H); 13C NMR (101 MHz, CDCl3) δ 170.51, 148.70, 138.97, 136.25, 136.13, 133.89, 132.51, 130.98, 
 - 10 -
128.50, 128.09, 127.28, 122.18, 121.74, 116.72, 84.26, 59.31, 38.74; HRMS (EI) m/z: 340.0976 
(M+); calc. for C19H17ClN2O2: 340.0979.  
(S)-3-(4-Bromophenyl)-2-methoxy-N-(quinolin-8-yl)propanamide (3k) 
 
The compound 3k was prepared according to the GP and purified by column chromatography in 
touene: ethyl acetate = 20:1. 3k was obtained as a light yellow oil (53.5 mg, 70%). 1H NMR (400 
MHz, CDCl3) δ 10.72 (s, 1H), 8.82 (dd, J = 4.1, 1.6 Hz, 1H), 8.79 (dd, J = 6.4, 2.5 Hz, 1H), 8.14 (dd, 
J = 8.3, 1.5 Hz, 1H), 7.59 – 7.49 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 7.38 (d, J = 8.3 Hz, 2H), 
7.20 (d, J = 8.2 Hz, 2H), 4.03 (dd, J = 8.2, 3.6 Hz, 1H), 3.50 (s, 3H), 3.24 (dd, J = 14.2, 3.4 Hz, 1H), 
3.03 (dd, J = 14.2, 8.2 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 170.48, 148.70, 138.98, 136.65, 
136.24, 133.90, 131.45, 131.38, 128.09, 127.28, 122.18, 121.74, 120.64, 116.74, 84.19, 59.31, 38.81; 
HRMS (EI) m/z: 384.0477 (M+); calc. for C19H17BrN2O2: 384.0473. 
(S)-3-(4-Acetylphenyl)-2-methoxy-N-(quinolin-8-yl)propanamide (3l) 
 
The compound 3l was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3l was obtained as a white solid (48.3 mg, 69%). 1H NMR (400 
MHz, CDCl3) δ 10.73 (s, 1H), 8.85 – 8.74 (m, 2H), 8.14 (dd, J = 8.3, 1.5 Hz, 1H), 7.86 (d, J = 8.2 
Hz, 2H), 7.58 – 7.50 (m, 2H), 7.46 – 7.38 (m, 3H), 4.09 (dd, J = 8.2, 3.6 Hz, 1H), 3.50 (s, 3H), 3.34 
(dd, J = 14.1, 3.6 Hz, 1H), 3.14 (dd, J = 14.1, 8.2 Hz, 1H), 2.53 (s, 3H); 13 C NMR (101 MHz, 
CDCl3) δ 197.96, 170.35, 148.68, 143.39, 138.92, 136.26, 135.68, 133.81, 129.83, 128.49, 128.05, 
127.27, 122.22, 121.75, 116.70, 84.00, 59.34, 39.33, 26.65; HRMS (EI) m/z: 348.1477 (M+); calc. 
for C21H20N2O3: 348.1474.  
(S)-2-Methoxy-3-(4-nitrophenyl)-N-(quinolin-8-yl)propanamide (3m) 
 
The compound 3m was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3m was obtained as a light yellow solid (39.5 mg, 56%). 1H 
NMR (400 MHz, CDCl3) δ 10.68 (s, 1H), 8.80 (d, J = 2.7 Hz, 1H), 8.78 – 8.65 (m, 1H), 8.15 (d, J = 
8.2 Hz, 1H), 8.11 (d, J = 8.4 Hz, 2H), 7.55 (d, J = 4.5 Hz, 2H), 7.51 – 7.39 (m, 3H), 4.11 (dd, J = 7.5, 
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3.6 Hz, 1H), 3.54 (s, 3H), 3.38 (dd, J = 14.0, 3.3 Hz, 1H), 3.21 (dd, J = 14.0, 7.7 Hz, 1H); 13C NMR 
(101 MHz, CDCl3) δ 169.92, 148.75, 147.03, 145.32, 138.95, 136.35, 133.67, 130.61, 128.12, 
127.29, 123.58, 122.42, 121.85, 116.81, 83.63, 59.36, 39.01; HRMS (EI) m/z: 351.1220 (M+); calc. 
for C19H17N3O4: 351.1219. 
(S)-3-(4-Cyanophenyl)-2-methoxy-N-(quinolin-8-yl)propanamide (3n) 
 
The compound 3n was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3n was obtained as a colorless oil (14.0 mg, 21% under 
standard conditions; 32.4 mg, 49% under conditions of 2.0 equiv. Ag2O and 2.0 mL DMF). 1H 
NMR (400 MHz, CDCl3) δ 10.67 (s, 1H), 8.82 (dd, J = 4.0, 1.2 Hz 1H), 8.76 (t, J = 4.4 Hz, 1H), 
8.16 (dd, J = 8.0, 1.2 Hz, 1H), 7.55 – 7.53 (m, 4H), 7.48 – 7.42 (m, 3H), 4.08 (dd, J = 8.0, 4.0 Hz, 
1H), 3.52 (s, 3H), 3.33 (dd, J = 14.0, 3.6 Hz, 1H), 3.16 (dd, J = 14.0, 8.0 Hz, 1H); 13C NMR (101 
MHz, CDCl3) δ 170.03, 148.77, 143.22, 138.98, 136.36, 133.74, 132.18, 130.54, 128.15, 127.32, 
122.39, 121.87, 119.09, 116.80, 110.69, 83.74, 59.36, 39.35; HRMS (EI) m/z: 331.1319 (M+); calc. 
for C20H17N3O2: 331.1321.  
(S)-2-Methoxy-N-(quinolin-8-yl)-3-(4-(trifluoromethyl)phenyl)propanamide (3o) 
 
The compound 3o was prepared according to the GP and purified by column chromatography in 
toluene: ethyl acetate = 12:1. 3o was obtained as a white solid (48.3 mg, 65%). 1H NMR (400 MHz, 
CDCl3) δ 10.72 (s, 1H), 8.86 – 8.70 (m, 2H), 8.15 (dd, J = 8.2, 1.0 Hz, 1H), 7.59 – 7.48 (m, 4H), 
7.47 – 7.40 (m, 3H), 4.08 (dd, J = 8.1, 3.5 Hz, 1H), 3.51 (s, 3H), 3.34 (dd, J = 14.2, 3.3 Hz, 1H), 
3.14 (dd, J = 14.1, 8.2 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 170.37, 148.74, 141.81, 138.98, 
136.29, 133.85, 131.14, 129.99, 129.48, 129.16, 129.00 (q, JC-F = 32.1 Hz), 128.12，127.30，125.30 
(q, JC-F = 3.6 Hz)，124.41 (q, JC-F = 270.2 Hz),122.28, 121.79，116.76, 84.06, 59.36, 39.22; HRMS 
(EI) m/z: 374.1241 (M+); calc. for C20H17F3N2O2: 374.1242. 
(S)-Methyl 4-(2-methoxy-3-oxo-3-(quinolin-8-ylamino)propyl)benzoate (3p) 
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The compound 3p was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3p was obtained as a white solid (48.2 mg, 66%). 1H NMR 
(400 MHz, CDCl3) δ 10.74 (s, 1H), 8.94 – 8.62 (m, 2H), 8.13 (dd, J = 8.2, 1.1 Hz, 1H), 7.94 (d, J = 
8.1 Hz, 2H), 7.62 – 7.48 (m, 2H), 7.47 – 7.33 (m, 3H), 4.08 (dd, J = 8.3, 3.5 Hz, 1H), 3.87 (s, 3H), 
3.49 (s, 3H), 3.34 (dd, J = 14.1, 3.3 Hz, 1H), 3.12 (dd, J = 14.1, 8.4 Hz, 1H); 13CNMR (101 MHz, 
CDCl3) δ 170.40, 167.14, 148.68, 143.18, 138.98, 136.24, 133.87, 129.70, 129.65, 128.63, 128.09, 
127.27, 122.19, 121.71, 116.73, 84.11, 59.34, 52.05, 39.43; HRMS (EI) m/z: 364.1419 (M+); calc. 
for C21H20N2O4: 364.1423.   
(S)-3-(3,4-Dimethylphenyl)-2-methoxy-N-(quinolin-8-yl)propanamide (3q) 
O HN
O
N
 
The compound 3q was prepared according to the GP and purified by column chromatography in 
toluene: ethyl acetate = 20:1. 3q was obtained as a colorless oil (50.5 mg, 76%). 1H NMR (400 MHz, 
CDCl3) δ 10.76 (s, 1H), 9.00 – 8.67 (m, 2H), 8.15 (dd, J = 8.2, 1.4 Hz, 1H), 7.62 – 7.50 (m, 2H), 
7.45 (dd, J = 8.2, 4.2 Hz, 1H), 7.17 – 6.96 (m, 3H), 4.06 (dd, J = 8.7, 3.4 Hz, 1H), 3.49 (s, 3H), 3.24 
(dd, J = 14.2, 3.3 Hz, 1H), 3.00 (dd, J = 14.2, 8.7 Hz, 1H), 2.20 (s, 6H); 13C NMR (101 MHz, CDCl3) 
δ 171.20, 148.65, 139.08, 136.49, 136.25, 135.20, 134.74, 134.15, 130.86, 129.71, 128.13, 127.37, 
126.85, 122.03, 121.71, 116.77, 84.88, 59.35, 39.34, 19.79, 19.44; HRMS (EI) m/z: 334.1685 (M+); 
calc. for C21H22N2O2: 334.1681. 
(S)-3-(3,4-Dimethoxyphenyl)-2-methoxy-N-(quinolin-8-yl)propanamide (3r) 
 
The compound 3r was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3r was obtained as a colorless oil (52.2 mg, 71%). 1H NMR 
(400 MHz, CDCl3) δ 10.72 (s, 1H), 9.00 – 8.63 (m, 2H), 8.14 (dd, J = 8.2, 1.4 Hz, 1H), 7.62 – 7.48 
(m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 6.95 – 6.80 (m, 2H), 6.76 (d, J = 8.6 Hz, 1H), 4.04 (dd, J = 
8.1, 3.5 Hz, 1H), 3.81 (s, 3H), 3.79 (s, 3H), 3.51 (s, 3H), 3.24 (dd, J = 14.3, 3.4 Hz, 1H), 3.03 (dd, J 
= 14.3, 8.1 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 170.98, 148.81, 148.66, 147.81, 138.99, 136.25, 
134.03, 130.22, 128.11, 127.29, 122.11, 121.74, 121.69, 116.66, 112.69, 111.14, 84.71, 59.32, 55.91, 
55.88, 39.14; HRMS (EI) m/z: 366.1577 (M+); calc. for C21H22N2O4: 366.1580.  
(S)-2-Methoxy-5-(2-methoxy-3-oxo-3-(quinolin-8-ylamino)propyl)phenyl acetate (3s) 
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The compound 3s was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3s was obtained as a colorless oil (54.1 mg, 69%). 1H NMR 
(400 MHz, CDCl3) δ 10.76 (s, 1H), 8.84 (dd, J = 4.0, 1.4 Hz, 1H), 8.80 (dd, J = 6.4, 2.3 Hz, 1H), 
8.15 (dd, J = 8.2, 1.4 Hz, 1H), 7.58 – 7.51 (m, 2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 7.16 (dd, J = 8.3, 
1.4 Hz, 1H), 7.06 (s, 1H), 6.86 (d, J = 8.3 Hz, 1H), 4.00 (dd, J = 8.6, 3.1 Hz, 1H), 3.78 (s, 3H), 3.49 
(s, 3H), 3.23 (dd, J = 14.3, 2.8 Hz, 1H), 2.98 (dd, J = 14.3, 8.7 Hz, 1H), 2.29 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ = 170.84, 169.14, 149.94, 148.71, 139.60, 139.06, 136.26, 134.03, 130.50, 128.13, 
127.82, 127.33, 124.09, 122.12, 121.74, 116.76, 112.37, 84.61, 59.45, 56.01, 38.69, 20.79; HRMS 
(EI) m/z: 394.1526 (M+); calc. for C22H22N2O5: 394.1529. 
(S)-3-(4-(Benzyloxy)-3-nitrophenyl)-2-methoxy-N-(quinolin-8-yl)propanamide (3t) 
 
The compound 3t was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3t was obtained as a colorless oil (57.5 mg, 63%). 1H NMR 
(400 MHz, CDCl3) δ 10.66 (s, 1H), 8.81 (dd, J = 4.0, 1.1 Hz, 1H), 8.76 (dd, J = 5.3, 3.6 Hz, 1H), 
8.14 (d, J = 8.2 Hz, 1H), 7.87 (s, 1H), 7.58 – 7.49 (m, 2H), 7.46 – 7.28 (m, 7H), 6.95 (d, J = 8.5 Hz, 
1H), 5.17 – 5.02 (m, 2H), 4.04 (dd, J = 7.3, 3.4 Hz, 1H), 3.54 (s, 3H), 3.25 (dd, J = 14.3, 3.3 Hz, 1H), 
3.08 (dd, J = 14.3, 7.6 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 170.11, 150.82, 148.76, 140.02, 
138.95, 136.24, 135.79, 135.21, 133.75, 130.34, 128.74, 128.24, 128.08, 127.26, 127.04, 126.78, 
122.27, 121.78, 116.78, 115.15, 83.78, 71.31, 59.24, 37.90; HRMS (EI) m/z: 457.1639 (M+); calc. 
for C26H23N3O5: 457.1638. 
(S)-3-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-methoxy-N-(quinolin-8-yl)propanamide (3u) 
 
The compound 3u was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3u was obtained as a colorless oil (46.8 mg, 64%). 1H NMR 
(400 MHz, CDCl3) δ 10.75 (s, 1H), 8.95 – 8.70 (m, 2H), 8.14 (dd, J = 8.2, 1.3 Hz, 1H), 7.60 – 7.49 
(m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 6.86 (s, 1H), 6.83 – 6.67 (m, 2H), 4.20 (s, 4H), 4.02 (dd, J = 
8.5, 3.4 Hz, 1H), 3.50 (s, 3H), 3.19 (dd, J = 14.3, 3.2 Hz, 1H), 2.96 (dd, J = 14.3, 8.5 Hz, 1H); 13C 
 - 14 -
NMR (101 MHz, CDCl3) δ 170.99, 148.66, 143.34, 142.35, 139.03, 136.25, 134.05, 131.02, 128.10, 
127.34, 122.52, 122.05, 121.70, 118.24, 117.09, 116.75, 84.62, 64.43, 64.40, 59.32, 38.86; HRMS 
(EI) m/z: 364.1427 (M+); calc. for C21H20N2O4: 364.1423.  
(S)-3-(4-(Hydroxymethyl)phenyl)-2-methoxy-N-(quinolin-8-yl)propanamide (3v) 
O HN
O
NHO
 
The compound 3v was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 2:1. 3v was obtained as a light yellow solid (39.6 mg, 59%). 1H 
NMR (400 MHz, CDCl3) δ 10.75 (s, 1H), 8.96 – 8.63 (m, 2H), 8.15 (dd, J = 8.2, 1.0 Hz, 1H), 7.59 – 
7.49 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 7.32 (d, J = 7.9 Hz, 2H), 7.27 (d, J = 8.6 Hz, 2H), 4.63 
(s, 2H), 4.05 (dd, J = 8.4, 3.5 Hz, 1H), 3.49 (s, 3H), 3.29 (dd, J = 14.2, 3.3 Hz, 1H), 3.07 (dd, J = 
14.2, 8.5 Hz, 1H), 1.78 (brs, 1H); 13C NMR (101 MHz, CDCl3) δ 170.90, 148.69, 139.29, 139.04, 
137.23, 136.29, 134.01, 129.79, 128.12, 127.36, 127.19, 122.14, 121.74, 116.78, 84.55, 65.29, 59.32, 
39.24; HRMS (EI) m/z: 336.1475 (M +); calc. for C20H20N2O3: 336.1474. 
(S)-2-Methoxy-N-(quinolin-8-yl)-3-(thiophen-2-yl)propanamide (3w) 
 
The compound 3w was prepared according to the GP and purified by column chromatography in 
toluene: ethyl acetate = 20:1. 3w was obtained as a light yellow oil (37.4 mg, 60%). 1H NMR (400 
MHz, CDCl3) δ 10.82 (s, 1H), 8.84 (d, J = 3.9 Hz, 1H), 8.81 (dd, J = 6.2, 2.4 Hz, 1H), 8.15 (d, J = 
8.2 Hz, 1H), 7.61 – 7.50 (m, 2H), 7.45 (dd, J = 8.2, 4.2 Hz, 1H), 7.15 (d, J = 5.0 Hz, 1H), 7.03 – 
6.93 (m, 1H), 6.94 – 6.82 (m, 1H), 4.06 (dd, J = 8.2, 3.2 Hz, 1H), 3.60 (s, 3H), 3.53 (dd, J = 15.3, 
3.0 Hz, 1H), 3.32 (dd, J = 15.2, 8.3 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 170.29, 148.73, 139.48, 
139.05, 136.27, 133.98, 128.12, 127.34, 126.74, 126.41, 124.54, 122.19, 121.76, 116.79, 84.03, 
59.34, 33.65; HRMS (EI) m/z: 312.0929 (M+); calc. for C17H16N2O2S: 312.0932. 
(S)-2-Methoxy-N-(quinolin-8-yl)-3-(1-tosyl-1H-indol-3-yl)propanamide (3x) 
O HN
O
NN
SO
O
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The compound 3x was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3x was obtained as a colorless oil (58.6 mg, 59%). 1H NMR 
(400 MHz, CDCl3) δ 10.79 (s, 1H), 8.83 (dd, J = 4.1, 1.6 Hz, 1H), 8.77 (dd, J = 4.9, 4.0 Hz, 1H), 
8.14 (dd, J = 8.3, 1.5 Hz, 1H), 7.91 (d, J = 7.9 Hz, 1H), 7.67 – 7.56 (m, 4H), 7.56 – 7.49 (m, 2H), 
7.44 (dd, J = 8.2, 4.2 Hz, 1H), 7.28 – 7.16 (m, 2H), 6.90 (d, J = 8.1 Hz, 2H), 4.13 (dd, J = 7.3, 3.7 
Hz, 1H), 3.52 (s, 3H), 3.35 (dd, J = 15.2, 3.5 Hz, 1H), 3.20 (dd, J = 15.2, 7.3 Hz, 1H), 2.17 (s, 3H); 
13C NMR (101 MHz, CDCl3) δ = 170.50, 148.80, 144.61, 138.99, 136.22, 135.36, 135.12, 133.94, 
131.27, 129.69, 128.09, 127.31, 126.71, 124.79, 124.65, 123.19, 122.15, 121.79, 119.81, 118.46, 
116.77, 113.67, 82.89, 59.15, 28.33, 21.49; HRMS (EI) m/z: 499.1570 (M+); calc. for C28H25N3O4S: 
499.1566. 
(S)-2-Methoxy-N-(quinolin-8-yl)-3-(4-(((2S,3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-((benzyloxy)m
ethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)propanamide (3y) 
 
The compound 3y was prepared according to the GP and purified by column chromatography in 
petroleum ether: ethyl acetate = 4:1. 3y was obtained as a white solid (117.0 mg, 67%). 1H NMR 
(400 MHz, CDCl3) δ 10.78 (s, 1H), 8.84 – 8.81 (m, 2H), 8.14 (dd, J = 8.4, 1.2 Hz, 1H), 7.58 – 7.52 
(m, 2H), 7.43 (dd, J = 8.0, 4.0 Hz, 1H), 7.31 – 7.25 (m, 21H), 7.20 – 7.18 (m, 2H), 7.01 (d, J = 8.4 
Hz, 2 H), 5.02 (d, J = 10.8 Hz, 1H), 4.96 – 4.93 (m, 2H), 4.86 – 4.79 (m, 3H), 4.60 – 4.50 (m, 3H), 
4.03 (dd, J = 8.8, 3.6 Hz, 1H), 3.78 (d, J = 10.4 Hz, 1H), 3.73 – 3.64 (m, 4H), 3.59 (dd, J = 8.0, 4.0 
Hz, 1H), 3.49 (s, 3H), 3.27 (dd, J = 14.0, 2.8 Hz, 1H), 3.03 (dd, J = 14.3, 8.4 Hz, 1H); 13C NMR 
(101 MHz, CDCl3) δ 170.94, 156.32, 148.69, 139.04, 138.65, 138.37, 138.26, 138.17, 136.26, 
134.05, 132.05, 130.63, 128.53, 128.51, 128.49, 128.47, 128.33, 128.12, 128.07, 127.99, 127.92, 
127.86, 127.76, 127.72, 127.34, 122.09, 121.74, 116.99, 116.91, 116.72, 102.01, 84.79, 84.71, 82.14, 
77.85, 75.86, 75.23, 75.16, 75.11, 73.61, 68.98, 59.38, 38.84; HRMS (ESI) m/z: 867.3567 (MNa+); 
calc. for C53H52N2O8: 867.3616. 
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Synthetic Applications 
 
(S)-tert-Butyl(2-methoxy-3-(4-methoxy-3-nitrophenyl)propanoyl)(quinolin-8-yl)carbamate (5a) 
 
To a solution of 3a (152.6 mg, 0.4 mmol) in dry MeCN (4 mL) were added di-tert-butyl dicarbonate 
(Boc2O, 261.9 mg, 1.2 mmol) and N,N-dimethylpyridin-4-amine (DMAP, 97.7 mg, 0.8 mmol). The 
mixture was stirred at room temperature for 4 hours. Then the reaction was diluted with 
dichloromethane (15 mL), washed by water (15 mL), brine (20 mL), and dried over anhydrous 
MgSO4. Evaporation of organic solvent and purification by column chromatography in petroleum 
ether: ethyl acetate = 2:1 gave the product 5a as a white solid (146.3 mg, 76%). 1H NMR (400 MHz, 
CDCl3) δ 8.86 (dd, J = 4.0, 1.5 Hz, 1H), 8.17 (dd, J = 8.3, 1.4 Hz, 1H), 7.92 (d, J = 1.7 Hz, 1H), 
7.83 (dd, J = 8.1, 1.1 Hz, 1H), 7.61 (dd, J = 8.6, 1.9 Hz, 1H), 7.56 (t, J = 7.7 Hz, 1H), 7.50 (dd, J = 
7.2, 1.0 Hz, 1H), 7.42 (dd, J = 8.3, 4.2 Hz, 1H), 7.02 (d, J = 8.6 Hz, 1H), 5.21 (dd, J = 8.5, 2.6 Hz, 
1H), 3.94 (s, 3H), 3.46 (dd, J = 13.4, 2.2 Hz, 1H), 3.38 (s, 3H), 3.01 (dd, J = 14.2, 8.6 Hz, 1H), 1.22 
(s, 9H); 13C NMR (101 MHz, CDCl3) δ 175.11, 152.98, 151.73, 150.54, 144.15, 139.53, 136.41, 
136.07, 135.84, 131.32, 129.05, 128.39, 126.74, 126.17, 121.72, 113.39, 83.26, 82.51, 58.27, 56.66, 
38.21, 27.72. 
(S)-2-Methoxy-3-(4-methoxy-3-nitrophenyl)propanoic acid (4a) 
 
To a solution of 5a (48.1 mg, 0.1 mmol) in THF/H2O (3:1, 0.5 mL) were added LiOH (4.8 mg, 0.2 
mmol) and H2O2 (30%, 50 μL, 0.5 mmol). The mixture was stirred at room temperature for 4 hours. 
Then the reaction was acidified by HCl (0.5 M, 12 mL), diluted with ethyl acetate (15 mL), washed by 
water (15 mL), brine (20 mL), and dried over anhydrous MgSO4. Evaporation of organic solvent and 
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purification by column chromatography in petroleum ether: ethyl acetate = 1:1 gave the product 4a as 
a light yellow oil (25.5 mg, 100%) with 4b (24.1 mg, 100%) isolated. 1H NMR (400 MHz, CDCl3) δ 
7.74 (d, J = 1.7 Hz, 1H), 7.44 (dd, J = 8.5, 1.8 Hz, 1H), 7.02 (d, J = 8.6 Hz, 1H), 3.99 (dd, J = 7.4, 
4.2 Hz, 1H), 3.94 (s, 3H), 3.42 (s, 3H), 3.12 (dd, J = 14.3, 4.0 Hz, 1H), 3.01 (dd, J = 14.4, 7.5 Hz, 
1H); 13C NMR (101 MHz, CDCl3) δ 175.99, 152.13, 139.48, 135.54, 129.03, 126.57, 113.72, 80.63, 
58.85, 56.68, 37.28; HRMS (EI) m/z: 255.0745 (M+); calc. for C11H13NO6: 255.0743. 
tert-Butyl quinolin-8-ylcarbamate (4b) 
NH
N
O
O
 
1H NMR (400 MHz, CDCl3) δ 9.02 (s, 1H), 8.79 (dd, J = 4.1, 1.5 Hz, 1H), 8.42 (d, J = 7.4 Hz, 1H), 
8.13 (dd, J = 8.2, 1.4 Hz, 1H), 7.51 (t, J = 8.0 Hz, 1H), 7.46 – 7.35 (m, 2H), 1.58 (s, 9H); 13C NMR 
(101 MHz, CDCl3) δ 153.05, 148.09, 138.41, 136.37, 135.35, 128.21, 127.49, 121.63, 120.28, 
114.59, 80.54, 28.55; HRMS (EI) m/z: 244.1210 (M+); calc. for C14H16N2O2: 244.1212. 
1-Iodo-4-(3-(4-phenoxyphenoxy)propoxy)benzene (2z) 
 
To a solution of 4-phenoxyphenol (1.86 g, 10 mmol) and 1,3-dibromopropane (10.09 g, 50 mmol) in 
anhydrous DMF (50 mL) was slowly added cesium carbonate (4.24 g, 13 mmol). The resulting 
suspension was heated at 65 °C overnight. After being allowed to cool to the room temperature, the 
reaction mixture was diluted with water (50 mL). Then the aqueous layer was extracted with Et2O (3 × 
50 mL). The organic layer was washed by brine (2 × 40 mL), and dried over anhydrous MgSO4. 
Evaporation of organic solvent and purification by column chromatography in petroleum ether: ethyl 
acetate = 50:1 gave the product 1-(3-bromopropoxy)-4-phenoxybenzene as a yellow liquid. 
To a solution of 4-iodophenol (1.32 g, 6 mmol) and 1-(3-bromopropoxy)-4-phenoxybenzene (2.03 g, 
6.6 mmol) in anhydrous DMF (30 mL) was slowly added cesium carbonate (2.35 g, 7.2 mmol). The 
resulting suspension was heated at 65 °C overnight. After being allowed to cool to the room 
temperature, the reaction mixture was diluted with water (30 mL). Then the aqueous layer was 
extracted with Et2O (3 × 40 mL). The organic layer was washed by brine (2 × 20 mL), and dried over 
anhydrous MgSO4. Evaporation of organic solvent and purification by column chromatography in 
petroleum ether: ethyl acetate = 50:1 gave the product 2z as a white solid. 1H NMR (400 MHz, 
CDCl3) δ 7.56 (d, J = 8.5 Hz, 2H), 7.31 (t, J = 7.7 Hz, 2H), 7.05 (t, J = 7.0 Hz, 2H), 7.00 – 6.93 (m, 
4H), 6.90 (d, J = 8.9 Hz, 2H), 6.71 (d, J = 8.5 Hz, 2H), 4.14 (t, J = 6.0 Hz, 4H), 2.31 – 2.21 (m, 2H); 
13C NMR (101 MHz, CDCl3) δ 158.88, 158.58, 155.22, 150.39, 138.35, 129.74, 122.59, 120.94, 
117.75, 117.06, 115.65, 82.90, 77.48, 77.16, 76.84, 64.87, 64.67, 29.38; HRMS (EI) m/z: 446.0381 
(M+); calc. for C21H19IO3: 446.0379.  
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(S)-2-Methoxy-3-(4-(3-(4-phenoxyphenoxy)propoxy)phenyl)-N-(quinolin-8-yl)propanamide 
(3z) 
 
The compound 3z was prepared according to the GP (using 1a and 2z as substrates) and purified by 
column chromatography in petroleum ether: ethyl acetate = 2:1. 3z was obtained as a light yellow oil 
(72.5 mg, 66%). 1H NMR (400 MHz, CDCl3) δ 10.74 (s, 1H), 8.91 – 8.71 (m, 2H), 8.15 (d, J = 7.6 
Hz, 1H), 7.63 – 7.49 (m, 2H), 7.44 (dd, J = 8.2, 4.2 Hz, 1H), 7.29 (t, J = 7.9 Hz, 2H), 7.25 (d, J = 
9.8 Hz, 2H), 7.04 (t, J = 7.4 Hz, 1H), 7.01 – 6.91 (m, 4H), 6.88 (d, J = 8.9 Hz, 2H), 6.83 (d, J = 8.4 
Hz, 2H), 4.12 (dd, J = 11.0, 5.6 Hz, 4H), 4.02 (dd, J = 8.3, 3.5 Hz, 1H), 3.49 (s, 3H), 3.24 (dd, J = 
14.3, 3.3 Hz, 1H), 3.02 (dd, J = 14.3, 8.4 Hz, 1H), 2.23 (dt, J = 11.8, 5.8 Hz, 2H); 13C NMR (101 
MHz, CDCl3) δ 170.97, 158.59, 157.68, 155.28, 150.26, 148.62, 138.98, 136.21, 134.03, 130.55, 
129.87, 129.69, 128.07, 127.30, 122.51, 122.03, 121.67, 120.90, 117.68, 116.68, 115.62, 114.44, 
84.73, 65.03, 64.40, 59.26, 38.65, 29.45; HRMS (EI) m/z: 548.2310 (M+); calc. for C34H32N2O5: 
548.2311. 
(S)-tert-Butyl-(2-methoxy-3-(4-(3-(4-phenoxyphenoxy)propoxy)phenyl)propanoyl)(quinolin-8-
yl)carbamate (5b) 
 
To a solution of 3z (53.5 mg, 0.1 mmol) in dry MeCN (1 mL) were added di-tert-butyl dicarbonate 
(Boc2O, 65.5 mg, 0.3 mmol) and N,N-dimethylpyridin-4-amine (DMAP, 24.4 mg, 0.2 mmol). The 
mixture was stirred at room temperature for 8 hours. Then the reaction was diluted with 
dichloromethane (10 mL), washed by water (10 mL), brine (10 mL), and dried over anhydrous 
MgSO4. Evaporation of organic solvent and purification by column chromatography in petroleum 
ether: ethyl acetate = 2:1 gave the product 5b as light yellow oil (53.2 mg, 82%). 1H NMR (400 
MHz, CDCl3) δ 8.86 (s, 1H), 8.14 (d, J = 8.1 Hz, 1H), 7.80 (d, J = 8.1 Hz, 1H), 7.53 (t, J = 7.7 Hz, 
1H), 7.43 (d, J = 7.2 Hz, 1H), 7.39 (dd, J = 7.9, 4.0 Hz, 1H), 7.36 – 7.22 (m, 4H), 7.14 – 6.72 (m, 
9H), 5.25 (d, J = 7.2 Hz, 1H), 4.15 (dd, J = 11.7, 5.7 Hz, 4H), 3.57 – 3.16 (m, 4H), 2.96 (dd, J = 
13.9, 9.0 Hz, 1H), 2.40 – 2.12 (m, 2H), 1.22 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 175.86, 158.63, 
157.60, 155.33, 152.90, 150.44, 150.23, 144.22, 136.63, 136.00, 130.85, 130.73, 129.70, 128.98, 
128.21, 126.14, 122.51, 121.63, 120.94, 117.68, 115.64, 114.35, 82.90, 65.08, 64.44, 58.30, 38.80, 
29.51, 27.70. 
(S)-2-Methoxy-3-(4-(3-(4-phenoxyphenoxy)propoxy)phenyl)propanoic acid (4c) 
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To a solution of 5b (45.1 mg, 0.07 mmol) in THF/H2O (3:1, 0.5 mL) were added LiOH (3.4 mg, 0.14 
mmol) and H2O2 (30%, 35 μL, 0.35 mmol). The mixture was stirred at room temperature for 4 hours. 
Then the reaction was acidified by HCl (0.5 M, 10 mL), diluted with ethyl acetate (10 mL), washed by 
water (10 mL), brine (10 mL), and dried over anhydrous MgSO4. Evaporation of organic solvent and 
purification by column chromatography in petroleum ether: ethyl acetate = 1:1 gave the product 4c as 
a light yellow oil (30.5 mg, 100%) with 4b (17.0 mg, 100%) isolated. 1H NMR (400 MHz, CDCl3) δ 
7.30 (t, J = 7.9 Hz, 2H), 7.17 (d, J = 8.3 Hz, 2H), 7.04 (t, J = 7.3 Hz, 1H), 7.00 – 6.91 (m, 4H), 6.91 
– 6.81 (m, 4H), 4.14 (t, J = 5.1 Hz, 4H), 3.98 (dd, J = 6.9, 4.1 Hz, 1H), 3.40 (s, 3H), 3.09 (dd, J = 
14.2, 3.8 Hz, 1H), 2.97 (dd, J = 14.2, 7.6 Hz, 1H), 2.30 – 2.20 (m, 2H); 13C NMR (101 MHz, CDCl3) 
δ 176.02, 158.62, 157.96, 155.30, 150.30, 130.57, 129.73, 128.75, 122.56, 120.95, 117.72, 115.65, 
114.56, 81.56, 65.03, 64.47, 58.76, 37.83, 29.50; HRMS (ESI) m/z: 421.4 ([M-H]-); calc. for 
C25H25O6-: 421.2. 
4-(2-(4-Iodophenoxy)ethyl)phenyl methanesulfonate (2aa) 
 
A mixture of 4-hydroxyphenethyl alcohol (2.76 g, 20 mmol) and triethylamine (8.8 mL, 63 mmol) in 
anhydrous dichloromethane (40 mL) was stirred at 0 °C. Then methane sulfonic chloride (4.0 ml, 50 
mmol) was slowly added to the solution. After stirring for 30 minutes, the reaction was diluted with 
ethyl acetate (20 mL), washed by aqueous NH4Cl (40 mL), brine (20 mL), and dried over anhydrous 
MgSO4. After evaporation of organic solvent, the crude product was directly used for the next step 
without any purification. 
The crude product 4-(2-((methylsulfonyl)oxy)ethyl)phenyl methanesulfonate (20 mmol) was 
dissolved in acetonitrile (30 mL). The resulting solution was then slowly added to a mixture of 
4-iodophenol (11.0 g, 50 mmol) and potassium carbonate (8.29g, 60.0 mmol) in acetonitrile (50 mL). 
The reaction was heated at a refluxing temperature for 3.0 h. After being allowed to cool to room 
temperature, the reaction mixture was filtered through a pad of Celite. After the evaporation of the 
solvent, the mixture was diluted with dichloromethane (50 mL), washed by water (40 mL), brine (20 
mL), and dried over anhydrous MgSO4. Evaporation of the solvent and purification by column 
chromatography in petroleum ether: ethyl acetate = 3:1 gave the product 2aa as a white solid. 1H 
NMR (400 MHz, CDCl3) δ 7.54 (d, J = 8.8 Hz, 2H), 7.32 (d, J = 8.4 Hz, 2H), 7.23 (d, J = 8.8 Hz, 2H), 
6.66 (d, J = 8.8 Hz, 2H), 4.13 (t, J = 6.8 Hz, 1H), 3.13 (s, 2H), 3.09 (t, J = 6.8 Hz, 1H);13C NMR (101 
MHz, CDCl3) δ 158.65, 148.05, 138.40, 137.80, 130.67, 122.18, 117.08, 83.09, 68.45, 37.48, 35.15; 
HRMS (EI) m/z: 417.9738 (M +); calc. for C15H15IO4S: 417.9736. 
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(S)-4-(2-(4-(2-Ethoxy-3-oxo-3-(quinolin-8-ylamino)propyl)phenoxy)ethyl)phenyl 
methanesulfonate (3aa) 
 
The compound 3aa was prepared according to the GP (using 1b and 2aa as substrates) and purified by 
column chromatography in petroleum ether: ethyl acetate = 2:1. 3aa was obtained as a light yellow oil 
(56.5 mg, 53%). 1H NMR (400 MHz, CDCl3) δ 10.92 (s, 1H), 8.91 – 8.70 (m, 2H), 8.13 (dd, J = 8.2, 
1.0 Hz, 1H), 7.59 – 7.48 (m, 2H), 7.42 (dd, J = 8.2, 4.2 Hz, 1H), 7.31 (d, J = 8.4 Hz, 2H), 7.27 – 
7.24 (m, 2H), 7.21 (d, J = 8.5 Hz, 2H), 6.80 (d, J = 8.4 Hz, 2H), 4.12 (t, J = 6.7 Hz, 2H), 4.05 (dd, J 
= 8.9, 3.1 Hz, 1H), 3.64 (tt, J = 14.0, 7.0 Hz, 1H), 3.49 (dq, J = 14.1, 7.0 Hz, 1H), 3.23 (dd, J = 14.2, 
3.0 Hz, 1H), 3.12 (s, 3H), 3.06 (t, J = 6.7 Hz, 2H), 2.97 (dd, J = 14.2, 9.0 Hz, 1H), 1.29 (t, J = 7.0 
Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 171.47, 157.40, 148.61, 147.96, 139.02, 138.13, 136.24, 
134.15, 130.66, 130.64, 130.49, 128.10, 127.34, 122.04, 121.99, 121.72, 116.56, 114.42, 82.93, 68.25, 
67.38, 39.04, 37.38, 35.24, 15.37; HRMS (EI) m/z: 534.1829 (M+); calc. for C29H30N2O6S: 534.1825. 
(S)-4-(2-(4-(3-((tert-Butoxycarbonyl)(quinolin-8-yl)amino)-2-ethoxy-3-oxopropyl)phenoxy)ethy
l)phenyl methanesulfonate (5c) 
 
To a solution of 3aa (53.5 mg, 0.1 mmol) in dry MeCN (1 mL) were added di-tert-butyl dicarbonate 
(Boc2O, 65.5 mg, 0.3 mmol) and N,N-dimethylpyridin-4-amine (DMAP, 24.4 mg, 0.2 mmol). The 
mixture was stirred at room temperature for 8 hours. Then the reaction was diluted with 
dichloromethane (10 mL), washed by water (10 mL), brine (10 mL), and dried over anhydrous 
MgSO4. Evaporation of organic solvent and purification by column chromatography in petroleum 
ether: ethyl acetate = 2:1 gave the product 5c as light yellow oil (44.0 mg, 69%). 1H NMR (400 MHz, 
CDCl3) δ 8.86 (dd, J = 4.1, 1.5 Hz, 1H), 8.16 (dd, J = 8.2, 1.4 Hz, 1H), 7.81 (d, J = 8.2 Hz, 1H), 
7.53 (t, J = 7.8 Hz, 1H), 7.46 – 7.37 (m, 2H), 7.36 – 7.31 (m, 3H), 7.23 (d, J = 8.6 Hz, 2H), 6.84 (d, 
J = 8.5 Hz, 2H), 5.34 – 5.21 (m, 1H), 4.18 (t, J = 6.7 Hz, 2H), 3.66 (dq, J = 14.0, 7.0 Hz, 1H), 3.44 – 
3.30 (m, 2H), 3.24 – 2.99 (m, 5H), 2.96 (dd, J = 14.0, 9.1 Hz, 1H), 1.22 (s, 9H), 1.11 (t, J = 7.0 Hz, 
3H); 13C NMR (101 MHz, CDCl3) δ 176.34, 157.33, 152.99, 150.45, 148.02, 144.30, 138.26, 136.78, 
136.01, 130.85, 130.73, 129.00, 128.19, 126.17, 122.08, 121.64, 114.33, 100.13, 82.86, 81.35, 68.34, 
66.13, 38.90, 37.40, 35.34, 27.75, 15.34. 
(S)-2-Ethoxy-3-(4-(4-((methylsulfonyl)oxy)phenethoxy)phenyl)propanoic acid (4d) 
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To a solution of 5c (38.1 mg, 0.06 mmol) in THF/H2O (3:1, 0.5 mL) were added LiOH (2.9 mg, 0.12 
mmol) and H2O2 (30%, 30 μL, 0.3 mmol). The mixture was stirred at room temperature for 4 hours. 
Then the reaction was acidified by HCl (0.5 M, 8 mL), diluted with ethyl acetate (10 mL), washed by 
water (10 mL), brine (10 mL), and dried over anhydrous MgSO4. Evaporation of organic solvent and 
purification by column chromatography in petroleum ether: ethyl acetate = 1:1 gave the product 4d as 
a light yellow oil (25.7 mg, 100%) with 4b (14.8 mg, 100%) isolated. 1H NMR (400 MHz, CDCl3) δ 
7.33 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 8.5 Hz, 2H), 7.15 (d, J = 8.4 Hz, 2H), 6.81 (d, J = 8.4 Hz, 2H), 
4.14 (t, J = 6.7 Hz, 2H), 4.04 (dd, J = 7.3, 4.2 Hz, 1H), 3.60 (dt, J = 14.0, 7.0 Hz, 1H), 3.49 – 3.37 
(m, 1H), 3.13 (s, 3H), 3.11 – 3.02 (m, 3H), 2.94 (dd, J = 14.1, 7.7 Hz, 1H), 1.17 (t, J = 6.9 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 175.13, 157.71, 147.98, 138.10, 130.70, 130.68, 128.98, 122.10, 
114.54, 79.89, 68.30, 66.97, 37.87, 37.42, 35.28, 15.18; HRMS (ESI) m/z: 407.5 ([M-H]-); calc. for 
C20H23O7S-: 407.2. 
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